FDA Inspection 1264213 — Robert E. Litman, M.D.
The FDA completed an inspection of Robert E. Litman, M.D. on March 4, 2025 in Gaithersburg, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 4, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Gaithersburg, MD (United States)
Additional Details
Clinical Investigator (CI)